Global Burden of Disease Health Financing Collaborator Network. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet 2017; 389: 2005–30 —The collaborators for this Article also include Lalit Dandona (Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA and Public Health Foundation of India, New Delhi, India), Rakhi Dandona (Public Health Foundation of India, New Delhi, India and Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA), and G Anil Kumar (Public Health Foundation of India, New Delhi, India).
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rwV1sN
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 4 January 2018 Source: European Journal of Radiology Author(s): Peiyao Zhang, Jing Wang, Qin Xu, Zhen...
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Zeinab Nazeeh Shata, Marwa R Amin, Heba M El-Kady, Mervat W Abu-Nazel Avicenna Journal of Medicine 2017 7(2):54-63 Background: Unlike ot...
-
Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation. Brain Topogr. 2017 Nov 23;: Authors: Wirsich J...
-
Abstract Diphenylarsinic acid (DPAA) is an organic arsenic compound used for the synthesis of chemical weapons. We previously found that th...
-
Vol.10 No.8 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/22FyVm0 via IFTTT
-
Whether to wear a pollution filter Development of air quality forecasting system in Macedonia, based on WRF-Chem model Abstract Urban air qu...
-
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2hMrBnH
-
To evaluate the effect of Recurrence Score® results (RS; Oncotype DX® multigene assay ODX) on treatment recommendations by Swiss multidiscip...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου